Journal Information
Vol. 14. Issue 4.
Pages 327 (July - August 2010)
Vol. 14. Issue 4.
Pages 327 (July - August 2010)
Letter to editor
Open Access
Overwhelming diffuse psoriasis during chronic HCV infection, after peginterferon-ribavirin treatment, supported by frequent resort to filgrastim rescue
Visits
3453
Sergio Sabbatani, Roberto Manfredi
Department of Clinical and Experimental Medicine, Division of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
This item has received

Under a Creative Commons license
Article information
Full text is only available in PDF
References
[1.]
M. Simin, J. Brok, D. Stimac, C. Gluud, L.L. Gluud.
Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C.
Aliment Pharmacol Ther, 25 (2007), pp. 1153-1162
[2.]
T. Yamamoto, H. Yokozeki, K. Nishioka.
Evaluation of psoriatic patients with HCV infection.
J Dermatol, 32 (2005), pp. 769-770
[3.]
S. Imafuku, A. Tashiro, M. Furue.
Ciclosporin treatment of psoriasis in a patient with chronic hepatitis C.
Br J Dermatol, 156 (2007), pp. 1367-1369
[4.]
G. Linardaki, O. Katsarou, P. Ioannidou, A. Rarafoulidou, K. Boki.
Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection.
J Rheumatol, 34 (2007), pp. 1353-1355
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools